Open AccessEarly Renal-Replacement Therapy May Reduce the All-Cause Mortality of Severe COVID-19: An Observational Cohort Study
Author(s) -
Jing Qian,
Mengjing Wang,
Huaizhou You,
Jianfeng Luo,
Shengqing Li,
Shu Chen,
Yijian Chen,
Xiantao Li,
Kangjie Wang,
Weichen Zhang,
Yuan Li,
Ni Li,
Jing Chen
Publication year - 2022
Publication title -
blood purification
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 57
eISSN - 1421-9735
pISSN - 0253-5068
DOI - 10.1159/000524229
Subject(s) - renal replacement therapy , medicine , covid-19 , observational study , intensive care medicine , cohort , cohort study , disease , virology , outbreak , infectious disease (medical specialty)
The efficacy of renal-replacement treatment (RRT) remains to be validated in COVID-19. In this retrospective cohort study, we aimed to assess the efficacy of early initiation of RRT in intensive care unit (ICU) adults with severe COVID-19.